Boomi World 2025: Accelerating What’s Next in AI, Integration, and the Connected Enterprise
24.4.2025 15:00:00 CEST | Business Wire | Press release
Boomi’s flagship event brings together global innovators shaping the future of AI, integration, and automation
Boomi™, the intelligent integration and automation leader, is excited to announce that Boomi World 2025 will be held May 12-15, 2025, in Dallas, Texas. This premier event will showcase the latest advancements in AI-driven integration and automation, bringing together industry leaders, innovative thinkers, and Boomi customers and partners to explore how these technologies are reshaping the future. Attendees will gain valuable insights on how to break down silos, streamline operations, and make informed, data-driven decisions through a series of keynote sessions, breakout discussions, and hands-on training opportunities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250424969941/en/
Boomi World 2025: Accelerating What’s Next in AI, Integration, and the Connected Enterprise
Emceed by technology industry veteran and correspondent Lisa Martin, Boomi World 2025 will feature esteemed speakers, including:
- Tara Davis-Woodhall and Hunter Woodhall, Olympic Power Couple
- Paul Fipps, President, Global Industries and Strategic Growth, ServiceNow
- Charles Davis, Director, Data & Analytics, Modern Niagara
- Shari Lava, Senior Director, AI and Automation, IDC
- Shawn Rogers, CEO, BARC US
- Matt Aslett, Director of Research, Analytics and Data, ISG Software Research
- Steve Lucas, Chairman and CEO, Boomi
- Ed Macosky, Chief Product and Technology Officer, Boomi
- Leaders from Infosys, Cognizant, and more!
Boomi World 2025 will feature an unparalleled lineup of keynote speakers and breakout sessions, giving attendees exclusive access to the insights and expertise of Boomi’s executive team, product leaders, customers, and partners. During the action-packed conference, attendees will explore the transformative power of agentic AI, get a peek behind the scenes at the Boomi product roadmap, and take a deep dive into real-world applications of API management (APIM), data management, integration, and automation.
Event Highlights:
| 1. | Special Guests Tara Davis-Woodhall and Hunter Woodhall
| |
| 2. | Exclusive Announcements Attendees will be the first to hear Boomi's latest product and platform updates, including product roadmap deep dives and planned strategic initiatives. Boomi World 2025 will feature exclusive announcements that will shape the future of AI, data management, API management, and integration and automation. | |
| 3. | Pre-Conference Training and Partner Summit
Starting on May 12, Boomi World will provide optional one and two-day Pre-Conference Training and certification courses, with in-depth sessions covering the various services within the Boomi Enterprise Platform, including integration, runtime architecture, API management, AI management, and data management.
| |
| 4. | 50+ Breakout Sessions Boomi World will offer more than 50 breakout sessions focused on AI, APIM, Data Management, and Integration: | |
AI (Artificial Intelligence) sessions cover the practical implementation and possibilities for enterprise AI, discussing Boomi AI Studio capabilities and running the gamut from orchestration and agentic AI to working with robots.
| ||
| 5. | Networking Opportunities Connect with technology thought-leaders, like-minded professionals, industry experts, and Boomi partners during dedicated networking sessions. Boomi World 2025 provides a unique platform to foster collaboration, share ideas, and build valuable relationships. |
Sponsors:
A special thanks to Boomi’s partner sponsors for helping make Boomi World 2025 possible, including ServiceNow as the Pinnacle sponsor, and Cognizant and Infosys as Diamond sponsors.
Registration:
Registration is open. Secure your spot at Boomi World 2025 by visiting BoomiWorld.com.
To join the Boomi World conversation on social media, use #BoomiWorld.
Additional Resources
- Follow Boomi on X (Twitter), LinkedIn, Facebook, and YouTube
About Boomi
Boomi, the intelligent integration and automation leader, helps organizations around the world automate and streamline critical processes to achieve business outcomes faster. Harnessing advanced AI capabilities, the Boomi Enterprise Platform seamlessly connects systems and manages data flows with API management, integration, data management, and AI orchestration in one comprehensive solution. With over 23,000 customers globally and a rapidly expanding network of 800+ partners, Boomi is revolutionizing the way enterprises of all sizes achieve business agility and operational excellence. Discover more at boomi.com.
© 2025 Boomi, LP. Boomi, the ‘B’ logo, and Boomiverse are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250424969941/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 13:00:00 CEST | Press release
Randomized controlled trial will evaluate both symptom progression and underlying biology Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom